Search results
Showing 4051 to 4065 of 8920 results
Good practice guidance – Integrated process statement (PMG12)
This process statement has been produced to explain how good practice guidance is developed. It provides an overview of the key process principles and describes all stages of the development of good practice guidance
Evidence summaries: unlicensed and off-label medicines – Integrated process statement (PMG14)
This integrated process statement has been produced to explain how 'Evidence summaries: unlicensed and off-label medicines' (ESUOMs) are developed. It provides an overview of the key process principles and describes all stages of development for ESUOMs
This guidance evaluates digital technologies, diagnostics and medical devices (including artificial intelligence).
Home What NICE does Our research work HTA Lab...
Past technology appraisal appeals and decisions
Evidence standards framework (ESF) for digital health technologies
NICE standards for innovators of digital health technologies and NHS commissioners
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social workers -...
Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.
NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.
Home What NICE does Our guidance About technology appraisal guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":
Getting involved as a voluntary and community sector organisation
Getting involved with NICE as a voluntary and community sector organisation
People can comment on our guidance at specific stages in its development.
Holding our meetings in public supports our commitment to having processes in place that are rigorous, open, and transparent.
Health inequalities can be experienced by people grouped by a range of different factors.
Transvaginal mesh repair of anterior or posterior vaginal wall prolapse (HTG456)
Evidence-based recommendations on transvaginal mesh repair of anterior or posterior vaginal wall prolapse. This involves inserting a mesh to replace tissue that has weakened and caused the pelvic organs to drop down (prolapse) into the vagina.